PF609 HEAVY&LIGHT CHAIN MONITORING IN HIGH RISK SMOLDERING MULTIPLE MYELOMA PATIENTS INCLUDED IN THE GEM‐CESAR TRIAL: COMPARISON WITH CONVENTIONAL AND MINIMAL RESIDUAL DISEASE IMWG RESPONSE ASSESSMENT Article Swipe
Noemí Puig
,
Teresa Contreras
,
Bruno Paiva
,
M.‐T. Cedena
,
J. Pérez
,
Irene Aires
,
Cristina Agulló
,
Joaquín Martínez‐López
,
Paula Rodríguez‐Otero
,
Verónica González‐Calle
,
Marta Sonia González
,
Albert Oriol
,
Norma C. Gutiérrez
,
Rafael Ríos
,
Laura Rosiñol
,
Miguel Ángel Álvarez-Avitia
,
Marı́a José Calasanz
,
Joan Bargay
,
Ana Pilar González-Rodríguez
,
Adrián Alegre
,
Fernando Escalante
,
Roxana Merino-Martinez
,
Javier de la Rubia
,
Ana Isabel Teruel
,
Felipe de Arriba
,
L. Palomera
,
M. Trevino Hernandez
,
José López Menéndez
,
Jesús Martín
,
Aránzazu García Mateo
,
Enrique M. Ocio
,
Joan Bladé
,
Juan José Lahuerta
,
Jesús F. San Miguel
,
María‐Victoria Mateos
·
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.1097/01.hs9.0000560724.00612.98
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.1097/01.hs9.0000560724.00612.98
Background: The GEM‐CESAR trial is a potentially curative strategy for high‐risk smoldering multiple myeloma (HRsMM) patients (pts) in which the primary endpoint is the assessment of bone marrow minimal residual disease (MRD) negativity. However, alternative methods of disease evaluation in serum such as heavy+light chain (HLC), with a potential added value to the IMWG response criteria, have also been tested. Aims: To analyze HLC disease in this group of pts at diagnosis and before maintenance, comparing the results with standard serological methods and with MRD assessed by Next Generation Flow (NGF). Methods: The 90 HRsMM pts included in the GEM‐CESAR trial received six 4‐weeks cycles of carfilzomib, lenalidomide and dexamethasone followed by high dose melphalan and 2 further cycles of consolidation with the same regimen. All pts received maintenance with lenalidomide up to 2 years. SPEP and IFE were performed using standard procedures. Serum IgGk, IgGl, IgAk and IgAl HLC concentrations were measured using Hevylite (The Binding Site Group Ltd, Birmingham, UK) on a SPA PLUS turbidimeter. HLC concentrations and ratios were considered abnormal if they were outside the 95% reference ranges provided by the manufacturer. MRD was analyzed by flow cytometry following EuroFlow recommendations. Standard response assignment was carried out as per the IMWG guidelines. HLC responses and HLC‐pair suppression were calculated as in Michalet et al (Leukemia 2018). Results: We analyzed 75 out of the 90 pts in the trial with intact immunoglobulin and available samples at diagnosis (50 IgG and 25 IgA). HLC ratio was abnormal in 98% (49/50) of the IgG pts and in 100% of IgA pts. A comparison of HLC‐ vs standard IMWG response rates post‐consolidation is detailed in Table 1. In the 60 cases with paired samples for both methods at this moment, there was a moderate agreement between them, with 78.3% of concordant results. The number of cases in the PR and VGPR groups is limited to extract any conclusion but among the 45 in CR as per the IMWG, there were 3 and 8 categorized as in PR and VGPR according to the HLC method, respectively. We then compared these results with those from the analysis of MRD by NGF in 59 out of the 60 cases with paired BM samples available. HLC and NGF reported concordant results in 71.1% of cases (42/59; HLC+/NGF+ in 15 cases and HLC‐/NGF‐ in 27 cases) and discordant in the remaining 28.9% (17/59; HLC‐/NGF+ in 7 cases and HLC+/NGF‐ in 10 cases). The percentage of positive cases post‐consolidation was 25% by SPEP, 37.2% by NGF and 43% by HLC. HLC‐pair suppression was identified in 13/60 pts (21.6%) and 10 of them (16.6%) had severe HLC‐pair suppression at the end of consolidation. After a median follow‐up of 32 months (8–128), 93% of pts remain alive and free of progression. We have analyzed responses post‐consolidation of the 2 cases included in this study that had already progressed. The first pt was in VGPR by the IMWG, in PR by HLC and MRD positive by NGF; the second one in RC by IMWG and by HLC but had severe HLC‐pair immunosuppression and was MRD positive by NGF. Summary/Conclusion: Response monitoring by HLC shows a moderate concordance with the IMWG response criteria as well as with MRD assessment by NGF. Most discordances are due to persistent disease by HLC while negative with the alternative methods, but longer follow‐up is needed to ascertain its clinical value. HLC assessment could have anticipated the progression noted in the 2 cases included in the study. image
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1097/01.hs9.0000560724.00612.98
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W3005868764
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W3005868764Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1097/01.hs9.0000560724.00612.98Digital Object Identifier
- Title
-
PF609 HEAVY&LIGHT CHAIN MONITORING IN HIGH RISK SMOLDERING MULTIPLE MYELOMA PATIENTS INCLUDED IN THE GEM‐CESAR TRIAL: COMPARISON WITH CONVENTIONAL AND MINIMAL RESIDUAL DISEASE IMWG RESPONSE ASSESSMENTWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2019Year of publication
- Publication date
-
2019-06-01Full publication date if available
- Authors
-
Noemí Puig, Teresa Contreras, Bruno Paiva, M.‐T. Cedena, J. Pérez, Irene Aires, Cristina Agulló, Joaquín Martínez‐López, Paula Rodríguez‐Otero, Verónica González‐Calle, Marta Sonia González, Albert Oriol, Norma C. Gutiérrez, Rafael Ríos, Laura Rosiñol, Miguel Ángel Álvarez-Avitia, Marı́a José Calasanz, Joan Bargay, Ana Pilar González-Rodríguez, Adrián Alegre, Fernando Escalante, Roxana Merino-Martinez, Javier de la Rubia, Ana Isabel Teruel, Felipe de Arriba, L. Palomera, M. Trevino Hernandez, José López Menéndez, Jesús Martín, Aránzazu García Mateo, Enrique M. Ocio, Joan Bladé, Juan José Lahuerta, Jesús F. San Miguel, María‐Victoria MateosList of authors in order
- Landing page
-
https://doi.org/10.1097/01.hs9.0000560724.00612.98Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1097/01.hs9.0000560724.00612.98Direct OA link when available
- Concepts
-
Medicine, Minimal residual disease, Lenalidomide, Multiple myeloma, Internal medicine, Daratumumab, Prednisone, Surgery, Oncology, Bone marrowTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W3005868764 |
|---|---|
| doi | https://doi.org/10.1097/01.hs9.0000560724.00612.98 |
| ids.doi | https://doi.org/10.1097/01.hs9.0000560724.00612.98 |
| ids.mag | 3005868764 |
| ids.openalex | https://openalex.org/W3005868764 |
| fwci | 0.0 |
| type | article |
| title | PF609 HEAVY&LIGHT CHAIN MONITORING IN HIGH RISK SMOLDERING MULTIPLE MYELOMA PATIENTS INCLUDED IN THE GEM‐CESAR TRIAL: COMPARISON WITH CONVENTIONAL AND MINIMAL RESIDUAL DISEASE IMWG RESPONSE ASSESSMENT |
| biblio.issue | S1 |
| biblio.volume | 3 |
| biblio.last_page | 258 |
| biblio.first_page | 258 |
| topics[0].id | https://openalex.org/T11752 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9139000177383423 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | Cancer Treatment and Pharmacology |
| is_xpac | False |
| apc_list.value | 1200 |
| apc_list.currency | USD |
| apc_list.value_usd | 1200 |
| apc_paid.value | 1200 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 1200 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8066544532775879 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2779823535 |
| concepts[1].level | 3 |
| concepts[1].score | 0.6732128262519836 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q6865356 |
| concepts[1].display_name | Minimal residual disease |
| concepts[2].id | https://openalex.org/C2776063141 |
| concepts[2].level | 3 |
| concepts[2].score | 0.667661190032959 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q425681 |
| concepts[2].display_name | Lenalidomide |
| concepts[3].id | https://openalex.org/C2776364478 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6054878830909729 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q467635 |
| concepts[3].display_name | Multiple myeloma |
| concepts[4].id | https://openalex.org/C126322002 |
| concepts[4].level | 1 |
| concepts[4].score | 0.5949236154556274 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[4].display_name | Internal medicine |
| concepts[5].id | https://openalex.org/C2781119759 |
| concepts[5].level | 4 |
| concepts[5].score | 0.44233232736587524 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q5222113 |
| concepts[5].display_name | Daratumumab |
| concepts[6].id | https://openalex.org/C2778720950 |
| concepts[6].level | 2 |
| concepts[6].score | 0.43036967515945435 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q424972 |
| concepts[6].display_name | Prednisone |
| concepts[7].id | https://openalex.org/C141071460 |
| concepts[7].level | 1 |
| concepts[7].score | 0.37787848711013794 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q40821 |
| concepts[7].display_name | Surgery |
| concepts[8].id | https://openalex.org/C143998085 |
| concepts[8].level | 1 |
| concepts[8].score | 0.3653297424316406 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[8].display_name | Oncology |
| concepts[9].id | https://openalex.org/C2780007613 |
| concepts[9].level | 2 |
| concepts[9].score | 0.27293938398361206 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q546523 |
| concepts[9].display_name | Bone marrow |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.8066544532775879 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/minimal-residual-disease |
| keywords[1].score | 0.6732128262519836 |
| keywords[1].display_name | Minimal residual disease |
| keywords[2].id | https://openalex.org/keywords/lenalidomide |
| keywords[2].score | 0.667661190032959 |
| keywords[2].display_name | Lenalidomide |
| keywords[3].id | https://openalex.org/keywords/multiple-myeloma |
| keywords[3].score | 0.6054878830909729 |
| keywords[3].display_name | Multiple myeloma |
| keywords[4].id | https://openalex.org/keywords/internal-medicine |
| keywords[4].score | 0.5949236154556274 |
| keywords[4].display_name | Internal medicine |
| keywords[5].id | https://openalex.org/keywords/daratumumab |
| keywords[5].score | 0.44233232736587524 |
| keywords[5].display_name | Daratumumab |
| keywords[6].id | https://openalex.org/keywords/prednisone |
| keywords[6].score | 0.43036967515945435 |
| keywords[6].display_name | Prednisone |
| keywords[7].id | https://openalex.org/keywords/surgery |
| keywords[7].score | 0.37787848711013794 |
| keywords[7].display_name | Surgery |
| keywords[8].id | https://openalex.org/keywords/oncology |
| keywords[8].score | 0.3653297424316406 |
| keywords[8].display_name | Oncology |
| keywords[9].id | https://openalex.org/keywords/bone-marrow |
| keywords[9].score | 0.27293938398361206 |
| keywords[9].display_name | Bone marrow |
| language | en |
| locations[0].id | doi:10.1097/01.hs9.0000560724.00612.98 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210211592 |
| locations[0].source.issn | 2572-9241 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2572-9241 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | HemaSphere |
| locations[0].source.host_organization | https://openalex.org/P4310318547 |
| locations[0].source.host_organization_name | Wolters Kluwer |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310318547 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | HemaSphere |
| locations[0].landing_page_url | https://doi.org/10.1097/01.hs9.0000560724.00612.98 |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A5047672322 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Noemí Puig |
| authorships[0].countries | ES |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I184999862 |
| authorships[0].affiliations[0].raw_affiliation_string | University Hospital of Salamanca, Salamanca |
| authorships[0].institutions[0].id | https://openalex.org/I184999862 |
| authorships[0].institutions[0].ror | https://ror.org/02f40zc51 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I184999862 |
| authorships[0].institutions[0].country_code | ES |
| authorships[0].institutions[0].display_name | Universidad de Salamanca |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | N. Puig |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | University Hospital of Salamanca, Salamanca |
| authorships[1].author.id | https://openalex.org/A5018808691 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Teresa Contreras |
| authorships[1].countries | ES |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I184999862 |
| authorships[1].affiliations[0].raw_affiliation_string | University Hospital of Salamanca, Salamanca |
| authorships[1].institutions[0].id | https://openalex.org/I184999862 |
| authorships[1].institutions[0].ror | https://ror.org/02f40zc51 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I184999862 |
| authorships[1].institutions[0].country_code | ES |
| authorships[1].institutions[0].display_name | Universidad de Salamanca |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | T. Contreras |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | University Hospital of Salamanca, Salamanca |
| authorships[2].author.id | https://openalex.org/A5057189669 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-1977-3815 |
| authorships[2].author.display_name | Bruno Paiva |
| authorships[2].countries | ES |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210135003 |
| authorships[2].affiliations[0].raw_affiliation_string | Clinica Universidad de Navarra, Pamplona |
| authorships[2].institutions[0].id | https://openalex.org/I4210135003 |
| authorships[2].institutions[0].ror | https://ror.org/03phm3r45 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210135003 |
| authorships[2].institutions[0].country_code | ES |
| authorships[2].institutions[0].display_name | Clinica Universidad de Navarra |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | B. Paiva |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Clinica Universidad de Navarra, Pamplona |
| authorships[3].author.id | https://openalex.org/A5072479027 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | M.‐T. Cedena |
| authorships[3].countries | ES |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210086614 |
| authorships[3].affiliations[0].raw_affiliation_string | Hospital 12 de octubre, Madrid |
| authorships[3].institutions[0].id | https://openalex.org/I4210086614 |
| authorships[3].institutions[0].ror | https://ror.org/002x1sg85 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210086614 |
| authorships[3].institutions[0].country_code | ES |
| authorships[3].institutions[0].display_name | Research Institute Hospital 12 de Octubre |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | M.‐T. Cedena |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Hospital 12 de octubre, Madrid |
| authorships[4].author.id | https://openalex.org/A5113894833 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | J. Pérez |
| authorships[4].countries | ES |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I184999862 |
| authorships[4].affiliations[0].raw_affiliation_string | University Hospital of Salamanca, Salamanca |
| authorships[4].institutions[0].id | https://openalex.org/I184999862 |
| authorships[4].institutions[0].ror | https://ror.org/02f40zc51 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I184999862 |
| authorships[4].institutions[0].country_code | ES |
| authorships[4].institutions[0].display_name | Universidad de Salamanca |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | J.J. Pérez |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | University Hospital of Salamanca, Salamanca |
| authorships[5].author.id | https://openalex.org/A5048499365 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Irene Aires |
| authorships[5].countries | ES |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I184999862 |
| authorships[5].affiliations[0].raw_affiliation_string | University Hospital of Salamanca, Salamanca |
| authorships[5].institutions[0].id | https://openalex.org/I184999862 |
| authorships[5].institutions[0].ror | https://ror.org/02f40zc51 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I184999862 |
| authorships[5].institutions[0].country_code | ES |
| authorships[5].institutions[0].display_name | Universidad de Salamanca |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | I. Aires |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | University Hospital of Salamanca, Salamanca |
| authorships[6].author.id | https://openalex.org/A5006758299 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Cristina Agulló |
| authorships[6].countries | ES |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I184999862 |
| authorships[6].affiliations[0].raw_affiliation_string | University Hospital of Salamanca, Salamanca |
| authorships[6].institutions[0].id | https://openalex.org/I184999862 |
| authorships[6].institutions[0].ror | https://ror.org/02f40zc51 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I184999862 |
| authorships[6].institutions[0].country_code | ES |
| authorships[6].institutions[0].display_name | Universidad de Salamanca |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | C. Agullo |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | University Hospital of Salamanca, Salamanca |
| authorships[7].author.id | https://openalex.org/A5034182883 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-7908-0063 |
| authorships[7].author.display_name | Joaquín Martínez‐López |
| authorships[7].countries | ES |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210086614 |
| authorships[7].affiliations[0].raw_affiliation_string | Hospital 12 de octubre, Madrid |
| authorships[7].institutions[0].id | https://openalex.org/I4210086614 |
| authorships[7].institutions[0].ror | https://ror.org/002x1sg85 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210086614 |
| authorships[7].institutions[0].country_code | ES |
| authorships[7].institutions[0].display_name | Research Institute Hospital 12 de Octubre |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | J. Martínez‐López |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Hospital 12 de octubre, Madrid |
| authorships[8].author.id | https://openalex.org/A5080959881 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-5236-7785 |
| authorships[8].author.display_name | Paula Rodríguez‐Otero |
| authorships[8].countries | ES |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210135003 |
| authorships[8].affiliations[0].raw_affiliation_string | Clinica Universidad de Navarra, Pamplona |
| authorships[8].institutions[0].id | https://openalex.org/I4210135003 |
| authorships[8].institutions[0].ror | https://ror.org/03phm3r45 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210135003 |
| authorships[8].institutions[0].country_code | ES |
| authorships[8].institutions[0].display_name | Clinica Universidad de Navarra |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | P. Rodríguez‐Otero |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Clinica Universidad de Navarra, Pamplona |
| authorships[9].author.id | https://openalex.org/A5046022528 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-5493-6707 |
| authorships[9].author.display_name | Verónica González‐Calle |
| authorships[9].countries | ES |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I184999862 |
| authorships[9].affiliations[0].raw_affiliation_string | University Hospital of Salamanca, Salamanca |
| authorships[9].institutions[0].id | https://openalex.org/I184999862 |
| authorships[9].institutions[0].ror | https://ror.org/02f40zc51 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I184999862 |
| authorships[9].institutions[0].country_code | ES |
| authorships[9].institutions[0].display_name | Universidad de Salamanca |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | V. González de la Calle |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | University Hospital of Salamanca, Salamanca |
| authorships[10].author.id | https://openalex.org/A5036432137 |
| authorships[10].author.orcid | https://orcid.org/0000-0001-5494-9009 |
| authorships[10].author.display_name | Marta Sonia González |
| authorships[10].countries | ES |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210096311 |
| authorships[10].affiliations[0].raw_affiliation_string | Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela |
| authorships[10].institutions[0].id | https://openalex.org/I4210096311 |
| authorships[10].institutions[0].ror | https://ror.org/00mpdg388 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210096311 |
| authorships[10].institutions[0].country_code | ES |
| authorships[10].institutions[0].display_name | Complejo Hospitalario Universitario de Santiago |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | M.‐S. González |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela |
| authorships[11].author.id | https://openalex.org/A5054952877 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-6804-2221 |
| authorships[11].author.display_name | Albert Oriol |
| authorships[11].countries | ES |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210153460 |
| authorships[11].affiliations[0].raw_affiliation_string | Hospital Germans Trias i Pujol, Badalona |
| authorships[11].institutions[0].id | https://openalex.org/I4210153460 |
| authorships[11].institutions[0].ror | https://ror.org/04wxdxa47 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I157913058, https://openalex.org/I4210153292, https://openalex.org/I4210153460 |
| authorships[11].institutions[0].country_code | ES |
| authorships[11].institutions[0].display_name | Hospital Universitari Germans Trias i Pujol |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | A. Oriol |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Hospital Germans Trias i Pujol, Badalona |
| authorships[12].author.id | https://openalex.org/A5047866471 |
| authorships[12].author.orcid | https://orcid.org/0000-0001-5834-9510 |
| authorships[12].author.display_name | Norma C. Gutiérrez |
| authorships[12].countries | ES |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I184999862 |
| authorships[12].affiliations[0].raw_affiliation_string | University Hospital of Salamanca, Salamanca |
| authorships[12].institutions[0].id | https://openalex.org/I184999862 |
| authorships[12].institutions[0].ror | https://ror.org/02f40zc51 |
| authorships[12].institutions[0].type | education |
| authorships[12].institutions[0].lineage | https://openalex.org/I184999862 |
| authorships[12].institutions[0].country_code | ES |
| authorships[12].institutions[0].display_name | Universidad de Salamanca |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | N.‐C. Gutiérrez |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | University Hospital of Salamanca, Salamanca |
| authorships[13].author.id | https://openalex.org/A5101595710 |
| authorships[13].author.orcid | https://orcid.org/0000-0001-8193-1402 |
| authorships[13].author.display_name | Rafael Ríos |
| authorships[13].countries | ES |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I4210116170 |
| authorships[13].affiliations[0].raw_affiliation_string | Hospital Virgen de las Nieves, Granada |
| authorships[13].institutions[0].id | https://openalex.org/I4210116170 |
| authorships[13].institutions[0].ror | https://ror.org/02f01mz90 |
| authorships[13].institutions[0].type | healthcare |
| authorships[13].institutions[0].lineage | https://openalex.org/I4210116170 |
| authorships[13].institutions[0].country_code | ES |
| authorships[13].institutions[0].display_name | Hospital Universitario Virgen de las Nieves |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | R. Rios |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Hospital Virgen de las Nieves, Granada |
| authorships[14].author.id | https://openalex.org/A5015898454 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-2534-9239 |
| authorships[14].author.display_name | Laura Rosiñol |
| authorships[14].countries | ES |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I4210115097 |
| authorships[14].affiliations[0].raw_affiliation_string | Hospital Clinic i Provincial, Barcelona |
| authorships[14].institutions[0].id | https://openalex.org/I4210115097 |
| authorships[14].institutions[0].ror | https://ror.org/02a2kzf50 |
| authorships[14].institutions[0].type | healthcare |
| authorships[14].institutions[0].lineage | https://openalex.org/I4210115097 |
| authorships[14].institutions[0].country_code | ES |
| authorships[14].institutions[0].display_name | Hospital Clínic de Barcelona |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | L. Rosiñol |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Hospital Clinic i Provincial, Barcelona |
| authorships[15].author.id | https://openalex.org/A5101971669 |
| authorships[15].author.orcid | https://orcid.org/0009-0002-1632-0298 |
| authorships[15].author.display_name | Miguel Ángel Álvarez-Avitia |
| authorships[15].countries | ES |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I4210123675 |
| authorships[15].affiliations[0].raw_affiliation_string | Hospital Reina Sofía Cordoba |
| authorships[15].institutions[0].id | https://openalex.org/I4210123675 |
| authorships[15].institutions[0].ror | https://ror.org/02vtd2q19 |
| authorships[15].institutions[0].type | healthcare |
| authorships[15].institutions[0].lineage | https://openalex.org/I158283456, https://openalex.org/I4210123675 |
| authorships[15].institutions[0].country_code | ES |
| authorships[15].institutions[0].display_name | Hospital Universitario Reina Sofía |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | M.A. Alvarez |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Hospital Reina Sofía Cordoba |
| authorships[16].author.id | https://openalex.org/A5091271737 |
| authorships[16].author.orcid | https://orcid.org/0000-0002-0374-3008 |
| authorships[16].author.display_name | Marı́a José Calasanz |
| authorships[16].countries | ES |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I4210135003 |
| authorships[16].affiliations[0].raw_affiliation_string | Clinica Universidad de Navarra, Pamplona |
| authorships[16].institutions[0].id | https://openalex.org/I4210135003 |
| authorships[16].institutions[0].ror | https://ror.org/03phm3r45 |
| authorships[16].institutions[0].type | healthcare |
| authorships[16].institutions[0].lineage | https://openalex.org/I4210135003 |
| authorships[16].institutions[0].country_code | ES |
| authorships[16].institutions[0].display_name | Clinica Universidad de Navarra |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | M.J. Calasanz |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Clinica Universidad de Navarra, Pamplona |
| authorships[17].author.id | https://openalex.org/A5035866456 |
| authorships[17].author.orcid | https://orcid.org/0000-0002-6739-3916 |
| authorships[17].author.display_name | Joan Bargay |
| authorships[17].countries | ES |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I4210087626 |
| authorships[17].affiliations[0].raw_affiliation_string | Hospital Son Llázter Palma de Mallorca |
| authorships[17].institutions[0].id | https://openalex.org/I4210087626 |
| authorships[17].institutions[0].ror | https://ror.org/003ez4w63 |
| authorships[17].institutions[0].type | healthcare |
| authorships[17].institutions[0].lineage | https://openalex.org/I4210087626 |
| authorships[17].institutions[0].country_code | ES |
| authorships[17].institutions[0].display_name | Hospital Son Llatzer |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | J. Bargay |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Hospital Son Llázter Palma de Mallorca |
| authorships[18].author.id | https://openalex.org/A5062126850 |
| authorships[18].author.orcid | https://orcid.org/0000-0002-0565-9133 |
| authorships[18].author.display_name | Ana Pilar González-Rodríguez |
| authorships[18].countries | ES |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I4210133994 |
| authorships[18].affiliations[0].raw_affiliation_string | Hospital Central de Asturias, Oviedo |
| authorships[18].institutions[0].id | https://openalex.org/I4210133994 |
| authorships[18].institutions[0].ror | https://ror.org/03v85ar63 |
| authorships[18].institutions[0].type | healthcare |
| authorships[18].institutions[0].lineage | https://openalex.org/I4210133994 |
| authorships[18].institutions[0].country_code | ES |
| authorships[18].institutions[0].display_name | Central University Hospital of Asturias |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | A.P. González |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | Hospital Central de Asturias, Oviedo |
| authorships[19].author.id | https://openalex.org/A5034430204 |
| authorships[19].author.orcid | https://orcid.org/0000-0002-2423-822X |
| authorships[19].author.display_name | Adrián Alegre |
| authorships[19].countries | ES |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I4210130498 |
| authorships[19].affiliations[0].raw_affiliation_string | Hospital La Princesa, Madrid |
| authorships[19].institutions[0].id | https://openalex.org/I4210130498 |
| authorships[19].institutions[0].ror | https://ror.org/03cg5md32 |
| authorships[19].institutions[0].type | healthcare |
| authorships[19].institutions[0].lineage | https://openalex.org/I4210130498, https://openalex.org/I4210139293 |
| authorships[19].institutions[0].country_code | ES |
| authorships[19].institutions[0].display_name | Hospital Universitario de La Princesa |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | A. Alegre |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | Hospital La Princesa, Madrid |
| authorships[20].author.id | https://openalex.org/A5036725271 |
| authorships[20].author.orcid | https://orcid.org/0000-0003-4501-9066 |
| authorships[20].author.display_name | Fernando Escalante |
| authorships[20].countries | ES |
| authorships[20].affiliations[0].institution_ids | https://openalex.org/I4210160075 |
| authorships[20].affiliations[0].raw_affiliation_string | Complejo Hospitalario de León León |
| authorships[20].institutions[0].id | https://openalex.org/I4210160075 |
| authorships[20].institutions[0].ror | https://ror.org/05gn84d31 |
| authorships[20].institutions[0].type | healthcare |
| authorships[20].institutions[0].lineage | https://openalex.org/I4210160075 |
| authorships[20].institutions[0].country_code | ES |
| authorships[20].institutions[0].display_name | Hospital de León |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | F. Escalante |
| authorships[20].is_corresponding | False |
| authorships[20].raw_affiliation_strings | Complejo Hospitalario de León León |
| authorships[21].author.id | https://openalex.org/A5101784527 |
| authorships[21].author.orcid | https://orcid.org/0000-0002-8939-0003 |
| authorships[21].author.display_name | Roxana Merino-Martinez |
| authorships[21].countries | ES |
| authorships[21].affiliations[0].institution_ids | https://openalex.org/I2961216182 |
| authorships[21].affiliations[0].raw_affiliation_string | Hospital Clínico San Carlos Madrid |
| authorships[21].institutions[0].id | https://openalex.org/I2961216182 |
| authorships[21].institutions[0].ror | https://ror.org/04d0ybj29 |
| authorships[21].institutions[0].type | healthcare |
| authorships[21].institutions[0].lineage | https://openalex.org/I2961216182, https://openalex.org/I4210139293 |
| authorships[21].institutions[0].country_code | ES |
| authorships[21].institutions[0].display_name | Hospital Clínico San Carlos |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | R. Martínez |
| authorships[21].is_corresponding | False |
| authorships[21].raw_affiliation_strings | Hospital Clínico San Carlos Madrid |
| authorships[22].author.id | https://openalex.org/A5032722606 |
| authorships[22].author.orcid | https://orcid.org/0000-0002-8354-768X |
| authorships[22].author.display_name | Javier de la Rubia |
| authorships[22].countries | ES |
| authorships[22].affiliations[0].institution_ids | https://openalex.org/I4210126200 |
| authorships[22].affiliations[0].raw_affiliation_string | Hospital Universitario Dr. Peset |
| authorships[22].institutions[0].id | https://openalex.org/I4210126200 |
| authorships[22].institutions[0].ror | https://ror.org/03971n288 |
| authorships[22].institutions[0].type | healthcare |
| authorships[22].institutions[0].lineage | https://openalex.org/I4210126200 |
| authorships[22].institutions[0].country_code | ES |
| authorships[22].institutions[0].display_name | Hospital Universitario Doctor Peset |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | J. de la Rubia |
| authorships[22].is_corresponding | False |
| authorships[22].raw_affiliation_strings | Hospital Universitario Dr. Peset |
| authorships[23].author.id | https://openalex.org/A5111917414 |
| authorships[23].author.orcid | |
| authorships[23].author.display_name | Ana Isabel Teruel |
| authorships[23].countries | ES |
| authorships[23].affiliations[0].institution_ids | https://openalex.org/I4210094406 |
| authorships[23].affiliations[0].raw_affiliation_string | Hospital Clínico Universitario Valencia |
| authorships[23].institutions[0].id | https://openalex.org/I4210094406 |
| authorships[23].institutions[0].ror | https://ror.org/00hpnj894 |
| authorships[23].institutions[0].type | healthcare |
| authorships[23].institutions[0].lineage | https://openalex.org/I4210094406 |
| authorships[23].institutions[0].country_code | ES |
| authorships[23].institutions[0].display_name | Hospital Clínico Universitario de Valencia |
| authorships[23].author_position | middle |
| authorships[23].raw_author_name | A.I. Teruel |
| authorships[23].is_corresponding | False |
| authorships[23].raw_affiliation_strings | Hospital Clínico Universitario Valencia |
| authorships[24].author.id | https://openalex.org/A5016479494 |
| authorships[24].author.orcid | https://orcid.org/0000-0002-4451-1318 |
| authorships[24].author.display_name | Felipe de Arriba |
| authorships[24].countries | ES |
| authorships[24].affiliations[0].institution_ids | https://openalex.org/I4210091031 |
| authorships[24].affiliations[0].raw_affiliation_string | Hospital Morales Meseguer, Murcia |
| authorships[24].institutions[0].id | https://openalex.org/I4210091031 |
| authorships[24].institutions[0].ror | https://ror.org/00cfm3y81 |
| authorships[24].institutions[0].type | healthcare |
| authorships[24].institutions[0].lineage | https://openalex.org/I4210091031 |
| authorships[24].institutions[0].country_code | ES |
| authorships[24].institutions[0].display_name | Hospital General Universitario Morales Meseguer |
| authorships[24].author_position | middle |
| authorships[24].raw_author_name | F. de Arriba |
| authorships[24].is_corresponding | False |
| authorships[24].raw_affiliation_strings | Hospital Morales Meseguer, Murcia |
| authorships[25].author.id | https://openalex.org/A5029958963 |
| authorships[25].author.orcid | https://orcid.org/0000-0002-7608-447X |
| authorships[25].author.display_name | L. Palomera |
| authorships[25].countries | ES |
| authorships[25].affiliations[0].institution_ids | https://openalex.org/I4210135032 |
| authorships[25].affiliations[0].raw_affiliation_string | Hospital Lozano Blesa, Zaragoza |
| authorships[25].institutions[0].id | https://openalex.org/I4210135032 |
| authorships[25].institutions[0].ror | https://ror.org/03fyv3102 |
| authorships[25].institutions[0].type | healthcare |
| authorships[25].institutions[0].lineage | https://openalex.org/I4210135032 |
| authorships[25].institutions[0].country_code | ES |
| authorships[25].institutions[0].display_name | Hospital Clínico Universitario Lozano Blesa |
| authorships[25].author_position | middle |
| authorships[25].raw_author_name | L. Palomera |
| authorships[25].is_corresponding | False |
| authorships[25].raw_affiliation_strings | Hospital Lozano Blesa, Zaragoza |
| authorships[26].author.id | https://openalex.org/A5103890114 |
| authorships[26].author.orcid | |
| authorships[26].author.display_name | M. Trevino Hernandez |
| authorships[26].countries | ES |
| authorships[26].affiliations[0].institution_ids | https://openalex.org/I2800401438 |
| authorships[26].affiliations[0].raw_affiliation_string | Hospital Universitario Santa Cruz de Tenerife, Santa Cruz de Tenerife |
| authorships[26].institutions[0].id | https://openalex.org/I2800401438 |
| authorships[26].institutions[0].ror | https://ror.org/05qndj312 |
| authorships[26].institutions[0].type | healthcare |
| authorships[26].institutions[0].lineage | https://openalex.org/I2800401438 |
| authorships[26].institutions[0].country_code | ES |
| authorships[26].institutions[0].display_name | Hospital Universitario de Canarias |
| authorships[26].author_position | middle |
| authorships[26].raw_author_name | M.T. Hernández |
| authorships[26].is_corresponding | False |
| authorships[26].raw_affiliation_strings | Hospital Universitario Santa Cruz de Tenerife, Santa Cruz de Tenerife |
| authorships[27].author.id | https://openalex.org/A5076401655 |
| authorships[27].author.orcid | https://orcid.org/0000-0002-4627-2277 |
| authorships[27].author.display_name | José López Menéndez |
| authorships[27].countries | ES |
| authorships[27].affiliations[0].institution_ids | https://openalex.org/I4210161852 |
| authorships[27].affiliations[0].raw_affiliation_string | Hospital Ramón y Cajal Madrid |
| authorships[27].institutions[0].id | https://openalex.org/I4210161852 |
| authorships[27].institutions[0].ror | https://ror.org/050eq1942 |
| authorships[27].institutions[0].type | healthcare |
| authorships[27].institutions[0].lineage | https://openalex.org/I4210139293, https://openalex.org/I4210161852 |
| authorships[27].institutions[0].country_code | ES |
| authorships[27].institutions[0].display_name | Hospital Universitario Ramón y Cajal |
| authorships[27].author_position | middle |
| authorships[27].raw_author_name | J. López |
| authorships[27].is_corresponding | False |
| authorships[27].raw_affiliation_strings | Hospital Ramón y Cajal Madrid |
| authorships[28].author.id | https://openalex.org/A5101490332 |
| authorships[28].author.orcid | https://orcid.org/0000-0003-4250-4824 |
| authorships[28].author.display_name | Jesús Martín |
| authorships[28].countries | ES |
| authorships[28].affiliations[0].institution_ids | https://openalex.org/I4210153139 |
| authorships[28].affiliations[0].raw_affiliation_string | Hospital Universitario Virgen del Rocío Sevilla |
| authorships[28].institutions[0].id | https://openalex.org/I4210153139 |
| authorships[28].institutions[0].ror | https://ror.org/04vfhnm78 |
| authorships[28].institutions[0].type | healthcare |
| authorships[28].institutions[0].lineage | https://openalex.org/I4210153139 |
| authorships[28].institutions[0].country_code | ES |
| authorships[28].institutions[0].display_name | Hospital Universitario Virgen del Rocío |
| authorships[28].author_position | middle |
| authorships[28].raw_author_name | J. Martín |
| authorships[28].is_corresponding | False |
| authorships[28].raw_affiliation_strings | Hospital Universitario Virgen del Rocío Sevilla |
| authorships[29].author.id | https://openalex.org/A5112014085 |
| authorships[29].author.orcid | |
| authorships[29].author.display_name | Aránzazu García Mateo |
| authorships[29].countries | ES |
| authorships[29].affiliations[0].institution_ids | https://openalex.org/I4210087353 |
| authorships[29].affiliations[0].raw_affiliation_string | Hospital General de Segovia, Segovia |
| authorships[29].institutions[0].id | https://openalex.org/I4210087353 |
| authorships[29].institutions[0].ror | https://ror.org/004qj2391 |
| authorships[29].institutions[0].type | healthcare |
| authorships[29].institutions[0].lineage | https://openalex.org/I4210087353, https://openalex.org/I4210123620 |
| authorships[29].institutions[0].country_code | ES |
| authorships[29].institutions[0].display_name | Hospital General De Segovia |
| authorships[29].author_position | middle |
| authorships[29].raw_author_name | A. García Mateo |
| authorships[29].is_corresponding | False |
| authorships[29].raw_affiliation_strings | Hospital General de Segovia, Segovia |
| authorships[30].author.id | https://openalex.org/A5008759843 |
| authorships[30].author.orcid | https://orcid.org/0000-0002-5765-0085 |
| authorships[30].author.display_name | Enrique M. Ocio |
| authorships[30].countries | ES |
| authorships[30].affiliations[0].institution_ids | https://openalex.org/I4210099858 |
| authorships[30].affiliations[0].raw_affiliation_string | Hospital Universitario Marqués de Valdecilla Santander Spain |
| authorships[30].institutions[0].id | https://openalex.org/I4210099858 |
| authorships[30].institutions[0].ror | https://ror.org/01w4yqf75 |
| authorships[30].institutions[0].type | healthcare |
| authorships[30].institutions[0].lineage | https://openalex.org/I4210099858 |
| authorships[30].institutions[0].country_code | ES |
| authorships[30].institutions[0].display_name | Marqués de Valdecilla University Hospital |
| authorships[30].author_position | middle |
| authorships[30].raw_author_name | E.M. Ocio |
| authorships[30].is_corresponding | False |
| authorships[30].raw_affiliation_strings | Hospital Universitario Marqués de Valdecilla Santander Spain |
| authorships[31].author.id | https://openalex.org/A5031837957 |
| authorships[31].author.orcid | https://orcid.org/0000-0002-4563-3405 |
| authorships[31].author.display_name | Joan Bladé |
| authorships[31].countries | ES |
| authorships[31].affiliations[0].institution_ids | https://openalex.org/I4210115097 |
| authorships[31].affiliations[0].raw_affiliation_string | Hospital Clinic i Provincial, Barcelona |
| authorships[31].institutions[0].id | https://openalex.org/I4210115097 |
| authorships[31].institutions[0].ror | https://ror.org/02a2kzf50 |
| authorships[31].institutions[0].type | healthcare |
| authorships[31].institutions[0].lineage | https://openalex.org/I4210115097 |
| authorships[31].institutions[0].country_code | ES |
| authorships[31].institutions[0].display_name | Hospital Clínic de Barcelona |
| authorships[31].author_position | middle |
| authorships[31].raw_author_name | J. Bladé |
| authorships[31].is_corresponding | False |
| authorships[31].raw_affiliation_strings | Hospital Clinic i Provincial, Barcelona |
| authorships[32].author.id | https://openalex.org/A5020420490 |
| authorships[32].author.orcid | https://orcid.org/0000-0002-3393-9570 |
| authorships[32].author.display_name | Juan José Lahuerta |
| authorships[32].countries | ES |
| authorships[32].affiliations[0].institution_ids | https://openalex.org/I4210086614 |
| authorships[32].affiliations[0].raw_affiliation_string | Hospital 12 de octubre, Madrid |
| authorships[32].institutions[0].id | https://openalex.org/I4210086614 |
| authorships[32].institutions[0].ror | https://ror.org/002x1sg85 |
| authorships[32].institutions[0].type | healthcare |
| authorships[32].institutions[0].lineage | https://openalex.org/I4210086614 |
| authorships[32].institutions[0].country_code | ES |
| authorships[32].institutions[0].display_name | Research Institute Hospital 12 de Octubre |
| authorships[32].author_position | middle |
| authorships[32].raw_author_name | J.J. Lahuerta |
| authorships[32].is_corresponding | False |
| authorships[32].raw_affiliation_strings | Hospital 12 de octubre, Madrid |
| authorships[33].author.id | https://openalex.org/A5020989412 |
| authorships[33].author.orcid | https://orcid.org/0000-0002-9183-4857 |
| authorships[33].author.display_name | Jesús F. San Miguel |
| authorships[33].countries | ES |
| authorships[33].affiliations[0].institution_ids | https://openalex.org/I4210135003 |
| authorships[33].affiliations[0].raw_affiliation_string | Clinica Universidad de Navarra, Pamplona |
| authorships[33].institutions[0].id | https://openalex.org/I4210135003 |
| authorships[33].institutions[0].ror | https://ror.org/03phm3r45 |
| authorships[33].institutions[0].type | healthcare |
| authorships[33].institutions[0].lineage | https://openalex.org/I4210135003 |
| authorships[33].institutions[0].country_code | ES |
| authorships[33].institutions[0].display_name | Clinica Universidad de Navarra |
| authorships[33].author_position | middle |
| authorships[33].raw_author_name | J. San Miguel |
| authorships[33].is_corresponding | False |
| authorships[33].raw_affiliation_strings | Clinica Universidad de Navarra, Pamplona |
| authorships[34].author.id | https://openalex.org/A5029159537 |
| authorships[34].author.orcid | https://orcid.org/0000-0003-2390-1218 |
| authorships[34].author.display_name | María‐Victoria Mateos |
| authorships[34].countries | ES |
| authorships[34].affiliations[0].institution_ids | https://openalex.org/I184999862 |
| authorships[34].affiliations[0].raw_affiliation_string | University Hospital of Salamanca, Salamanca |
| authorships[34].institutions[0].id | https://openalex.org/I184999862 |
| authorships[34].institutions[0].ror | https://ror.org/02f40zc51 |
| authorships[34].institutions[0].type | education |
| authorships[34].institutions[0].lineage | https://openalex.org/I184999862 |
| authorships[34].institutions[0].country_code | ES |
| authorships[34].institutions[0].display_name | Universidad de Salamanca |
| authorships[34].author_position | last |
| authorships[34].raw_author_name | M.V. Mateos |
| authorships[34].is_corresponding | False |
| authorships[34].raw_affiliation_strings | University Hospital of Salamanca, Salamanca |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1097/01.hs9.0000560724.00612.98 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | PF609 HEAVY&LIGHT CHAIN MONITORING IN HIGH RISK SMOLDERING MULTIPLE MYELOMA PATIENTS INCLUDED IN THE GEM‐CESAR TRIAL: COMPARISON WITH CONVENTIONAL AND MINIMAL RESIDUAL DISEASE IMWG RESPONSE ASSESSMENT |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11752 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9139000177383423 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | Cancer Treatment and Pharmacology |
| related_works | https://openalex.org/W4366082830, https://openalex.org/W4229333964, https://openalex.org/W2510398184, https://openalex.org/W4233225695, https://openalex.org/W2215729572, https://openalex.org/W4387003806, https://openalex.org/W2605594161, https://openalex.org/W3121407702, https://openalex.org/W3217566318, https://openalex.org/W4320925653 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1097/01.hs9.0000560724.00612.98 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210211592 |
| best_oa_location.source.issn | 2572-9241 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2572-9241 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | HemaSphere |
| best_oa_location.source.host_organization | https://openalex.org/P4310318547 |
| best_oa_location.source.host_organization_name | Wolters Kluwer |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310318547 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | HemaSphere |
| best_oa_location.landing_page_url | https://doi.org/10.1097/01.hs9.0000560724.00612.98 |
| primary_location.id | doi:10.1097/01.hs9.0000560724.00612.98 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210211592 |
| primary_location.source.issn | 2572-9241 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2572-9241 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | HemaSphere |
| primary_location.source.host_organization | https://openalex.org/P4310318547 |
| primary_location.source.host_organization_name | Wolters Kluwer |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310318547 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | HemaSphere |
| primary_location.landing_page_url | https://doi.org/10.1097/01.hs9.0000560724.00612.98 |
| publication_date | 2019-06-01 |
| publication_year | 2019 |
| referenced_works_count | 0 |
| abstract_inverted_index.2 | 116, 133, 470, 576 |
| abstract_inverted_index.3 | 330 |
| abstract_inverted_index.7 | 400 |
| abstract_inverted_index.8 | 332 |
| abstract_inverted_index.A | 262 |
| abstract_inverted_index.a | 5, 47, 163, 292, 447, 525 |
| abstract_inverted_index.1. | 276 |
| abstract_inverted_index.10 | 405, 433 |
| abstract_inverted_index.15 | 384 |
| abstract_inverted_index.25 | 243 |
| abstract_inverted_index.27 | 389 |
| abstract_inverted_index.32 | 451 |
| abstract_inverted_index.45 | 321 |
| abstract_inverted_index.59 | 360 |
| abstract_inverted_index.60 | 279, 364 |
| abstract_inverted_index.75 | 223 |
| abstract_inverted_index.90 | 93, 227 |
| abstract_inverted_index.BM | 368 |
| abstract_inverted_index.CR | 323 |
| abstract_inverted_index.In | 277 |
| abstract_inverted_index.PR | 308, 336, 490 |
| abstract_inverted_index.RC | 502 |
| abstract_inverted_index.To | 61 |
| abstract_inverted_index.We | 221, 345, 463 |
| abstract_inverted_index.al | 217 |
| abstract_inverted_index.as | 42, 201, 213, 324, 334, 533, 535 |
| abstract_inverted_index.at | 70, 238, 287, 441 |
| abstract_inverted_index.by | 86, 111, 183, 189, 357, 415, 418, 422, 486, 491, 496, 503, 506, 517, 522, 539, 548 |
| abstract_inverted_index.et | 216 |
| abstract_inverted_index.if | 174 |
| abstract_inverted_index.in | 17, 39, 65, 97, 214, 229, 249, 257, 274, 306, 322, 335, 359, 377, 383, 388, 393, 399, 404, 428, 473, 484, 489, 501, 574, 579 |
| abstract_inverted_index.is | 4, 22, 272, 312, 559 |
| abstract_inverted_index.of | 25, 36, 68, 105, 119, 225, 252, 259, 264, 299, 304, 355, 362, 379, 409, 434, 444, 450, 455, 461, 468 |
| abstract_inverted_index.on | 162 |
| abstract_inverted_index.pt | 482 |
| abstract_inverted_index.to | 51, 132, 314, 340, 545, 561 |
| abstract_inverted_index.up | 131 |
| abstract_inverted_index.vs | 266 |
| abstract_inverted_index.(50 | 240 |
| abstract_inverted_index.25% | 414 |
| abstract_inverted_index.43% | 421 |
| abstract_inverted_index.93% | 454 |
| abstract_inverted_index.95% | 179 |
| abstract_inverted_index.98% | 250 |
| abstract_inverted_index.All | 125 |
| abstract_inverted_index.HLC | 63, 149, 167, 206, 245, 342, 371, 492, 507, 523, 549, 566 |
| abstract_inverted_index.IFE | 137 |
| abstract_inverted_index.IgA | 260 |
| abstract_inverted_index.IgG | 241, 254 |
| abstract_inverted_index.MRD | 84, 186, 356, 494, 515, 537 |
| abstract_inverted_index.NGF | 358, 373, 419 |
| abstract_inverted_index.SPA | 164 |
| abstract_inverted_index.The | 1, 92, 302, 407, 480 |
| abstract_inverted_index.UK) | 161 |
| abstract_inverted_index.and | 72, 82, 108, 115, 136, 147, 169, 208, 235, 242, 256, 309, 331, 337, 372, 386, 391, 402, 420, 432, 459, 493, 505, 513 |
| abstract_inverted_index.any | 316 |
| abstract_inverted_index.are | 543 |
| abstract_inverted_index.but | 318, 508, 556 |
| abstract_inverted_index.due | 544 |
| abstract_inverted_index.end | 443 |
| abstract_inverted_index.for | 9, 284 |
| abstract_inverted_index.had | 437, 477, 509 |
| abstract_inverted_index.its | 563 |
| abstract_inverted_index.one | 500 |
| abstract_inverted_index.out | 200, 224, 361 |
| abstract_inverted_index.per | 202, 325 |
| abstract_inverted_index.pts | 69, 95, 126, 228, 255, 430, 456 |
| abstract_inverted_index.six | 102 |
| abstract_inverted_index.the | 19, 23, 52, 76, 98, 122, 178, 184, 203, 226, 230, 253, 278, 307, 320, 326, 341, 353, 363, 394, 442, 469, 487, 498, 529, 553, 571, 575, 580 |
| abstract_inverted_index.was | 187, 198, 247, 291, 413, 426, 483, 514 |
| abstract_inverted_index.(The | 155 |
| abstract_inverted_index.100% | 258 |
| abstract_inverted_index.Flow | 89 |
| abstract_inverted_index.HLC. | 423 |
| abstract_inverted_index.IMWG | 53, 204, 268, 504, 530 |
| abstract_inverted_index.IgAk | 146 |
| abstract_inverted_index.IgAl | 148 |
| abstract_inverted_index.Ltd, | 159 |
| abstract_inverted_index.Most | 541 |
| abstract_inverted_index.NGF. | 518, 540 |
| abstract_inverted_index.NGF; | 497 |
| abstract_inverted_index.Next | 87 |
| abstract_inverted_index.PLUS | 165 |
| abstract_inverted_index.SPEP | 135 |
| abstract_inverted_index.Site | 157 |
| abstract_inverted_index.VGPR | 310, 338, 485 |
| abstract_inverted_index.also | 57 |
| abstract_inverted_index.been | 58 |
| abstract_inverted_index.bone | 26 |
| abstract_inverted_index.both | 285 |
| abstract_inverted_index.dose | 113 |
| abstract_inverted_index.flow | 190 |
| abstract_inverted_index.free | 460 |
| abstract_inverted_index.from | 352 |
| abstract_inverted_index.have | 56, 464, 569 |
| abstract_inverted_index.high | 112 |
| abstract_inverted_index.pts. | 261 |
| abstract_inverted_index.same | 123 |
| abstract_inverted_index.such | 41 |
| abstract_inverted_index.that | 476 |
| abstract_inverted_index.them | 435 |
| abstract_inverted_index.then | 346 |
| abstract_inverted_index.they | 175 |
| abstract_inverted_index.this | 66, 288, 474 |
| abstract_inverted_index.well | 534 |
| abstract_inverted_index.were | 138, 151, 171, 176, 211, 329 |
| abstract_inverted_index.with | 46, 78, 83, 121, 129, 232, 281, 297, 350, 366, 528, 536, 552 |
| abstract_inverted_index.(MRD) | 31 |
| abstract_inverted_index.(pts) | 16 |
| abstract_inverted_index.13/60 | 429 |
| abstract_inverted_index.28.9% | 396 |
| abstract_inverted_index.37.2% | 417 |
| abstract_inverted_index.71.1% | 378 |
| abstract_inverted_index.78.3% | 298 |
| abstract_inverted_index.After | 446 |
| abstract_inverted_index.Aims: | 60 |
| abstract_inverted_index.Group | 158 |
| abstract_inverted_index.HRsMM | 94 |
| abstract_inverted_index.IMWG, | 327, 488 |
| abstract_inverted_index.IgA). | 244 |
| abstract_inverted_index.IgGk, | 144 |
| abstract_inverted_index.IgGl, | 145 |
| abstract_inverted_index.SPEP, | 416 |
| abstract_inverted_index.Serum | 143 |
| abstract_inverted_index.Table | 275 |
| abstract_inverted_index.added | 49 |
| abstract_inverted_index.alive | 458 |
| abstract_inverted_index.among | 319 |
| abstract_inverted_index.cases | 280, 305, 365, 380, 385, 401, 411, 471, 577 |
| abstract_inverted_index.chain | 44 |
| abstract_inverted_index.could | 568 |
| abstract_inverted_index.first | 481 |
| abstract_inverted_index.group | 67 |
| abstract_inverted_index.image | 582 |
| abstract_inverted_index.noted | 573 |
| abstract_inverted_index.rates | 270 |
| abstract_inverted_index.ratio | 246 |
| abstract_inverted_index.serum | 40 |
| abstract_inverted_index.shows | 524 |
| abstract_inverted_index.study | 475 |
| abstract_inverted_index.them, | 296 |
| abstract_inverted_index.there | 290, 328 |
| abstract_inverted_index.these | 348 |
| abstract_inverted_index.those | 351 |
| abstract_inverted_index.trial | 3, 100, 231 |
| abstract_inverted_index.using | 140, 153 |
| abstract_inverted_index.value | 50 |
| abstract_inverted_index.which | 18 |
| abstract_inverted_index.while | 550 |
| abstract_inverted_index.(HLC), | 45 |
| abstract_inverted_index.(NGF). | 90 |
| abstract_inverted_index.2018). | 219 |
| abstract_inverted_index.HLC‐ | 265 |
| abstract_inverted_index.before | 73 |
| abstract_inverted_index.cases) | 390 |
| abstract_inverted_index.cycles | 104, 118 |
| abstract_inverted_index.groups | 311 |
| abstract_inverted_index.intact | 233 |
| abstract_inverted_index.longer | 557 |
| abstract_inverted_index.marrow | 27 |
| abstract_inverted_index.median | 448 |
| abstract_inverted_index.months | 452 |
| abstract_inverted_index.needed | 560 |
| abstract_inverted_index.number | 303 |
| abstract_inverted_index.paired | 282, 367 |
| abstract_inverted_index.ranges | 181 |
| abstract_inverted_index.ratios | 170 |
| abstract_inverted_index.remain | 457 |
| abstract_inverted_index.second | 499 |
| abstract_inverted_index.severe | 438, 510 |
| abstract_inverted_index.study. | 581 |
| abstract_inverted_index.value. | 565 |
| abstract_inverted_index.years. | 134 |
| abstract_inverted_index.(16.6%) | 436 |
| abstract_inverted_index.(17/59; | 397 |
| abstract_inverted_index.(21.6%) | 431 |
| abstract_inverted_index.(42/59; | 381 |
| abstract_inverted_index.(49/50) | 251 |
| abstract_inverted_index.(HRsMM) | 14 |
| abstract_inverted_index.Binding | 156 |
| abstract_inverted_index.already | 478 |
| abstract_inverted_index.analyze | 62 |
| abstract_inverted_index.between | 295 |
| abstract_inverted_index.carried | 199 |
| abstract_inverted_index.cases). | 406 |
| abstract_inverted_index.disease | 30, 37, 64, 547 |
| abstract_inverted_index.extract | 315 |
| abstract_inverted_index.further | 117 |
| abstract_inverted_index.limited | 313 |
| abstract_inverted_index.method, | 343 |
| abstract_inverted_index.methods | 35, 81, 286 |
| abstract_inverted_index.minimal | 28 |
| abstract_inverted_index.moment, | 289 |
| abstract_inverted_index.myeloma | 13 |
| abstract_inverted_index.outside | 177 |
| abstract_inverted_index.primary | 20 |
| abstract_inverted_index.results | 77, 349, 376 |
| abstract_inverted_index.samples | 237, 283, 369 |
| abstract_inverted_index.tested. | 59 |
| abstract_inverted_index.EuroFlow | 193 |
| abstract_inverted_index.Hevylite | 154 |
| abstract_inverted_index.However, | 33 |
| abstract_inverted_index.Methods: | 91 |
| abstract_inverted_index.Michalet | 215 |
| abstract_inverted_index.Response | 520 |
| abstract_inverted_index.Results: | 220 |
| abstract_inverted_index.Standard | 195 |
| abstract_inverted_index.abnormal | 173, 248 |
| abstract_inverted_index.analysis | 354 |
| abstract_inverted_index.analyzed | 188, 222, 465 |
| abstract_inverted_index.assessed | 85 |
| abstract_inverted_index.clinical | 564 |
| abstract_inverted_index.compared | 347 |
| abstract_inverted_index.criteria | 532 |
| abstract_inverted_index.curative | 7 |
| abstract_inverted_index.detailed | 273 |
| abstract_inverted_index.endpoint | 21 |
| abstract_inverted_index.followed | 110 |
| abstract_inverted_index.included | 96, 472, 578 |
| abstract_inverted_index.measured | 152 |
| abstract_inverted_index.methods, | 555 |
| abstract_inverted_index.moderate | 293, 526 |
| abstract_inverted_index.multiple | 12 |
| abstract_inverted_index.negative | 551 |
| abstract_inverted_index.patients | 15 |
| abstract_inverted_index.positive | 410, 495, 516 |
| abstract_inverted_index.provided | 182 |
| abstract_inverted_index.received | 101, 127 |
| abstract_inverted_index.regimen. | 124 |
| abstract_inverted_index.reported | 374 |
| abstract_inverted_index.residual | 29 |
| abstract_inverted_index.response | 54, 196, 269, 531 |
| abstract_inverted_index.results. | 301 |
| abstract_inverted_index.standard | 79, 141, 267 |
| abstract_inverted_index.strategy | 8 |
| abstract_inverted_index.(Leukemia | 218 |
| abstract_inverted_index.4‐weeks | 103 |
| abstract_inverted_index.HLC+/NGF+ | 382 |
| abstract_inverted_index.according | 339 |
| abstract_inverted_index.agreement | 294 |
| abstract_inverted_index.ascertain | 562 |
| abstract_inverted_index.available | 236 |
| abstract_inverted_index.comparing | 75 |
| abstract_inverted_index.criteria, | 55 |
| abstract_inverted_index.cytometry | 191 |
| abstract_inverted_index.diagnosis | 71, 239 |
| abstract_inverted_index.following | 192 |
| abstract_inverted_index.melphalan | 114 |
| abstract_inverted_index.performed | 139 |
| abstract_inverted_index.potential | 48 |
| abstract_inverted_index.reference | 180 |
| abstract_inverted_index.remaining | 395 |
| abstract_inverted_index.responses | 207, 466 |
| abstract_inverted_index.(8–128), | 453 |
| abstract_inverted_index.Generation | 88 |
| abstract_inverted_index.HLC‐pair | 209, 424, 439, 511 |
| abstract_inverted_index.assessment | 24, 538, 567 |
| abstract_inverted_index.assignment | 197 |
| abstract_inverted_index.available. | 370 |
| abstract_inverted_index.calculated | 212 |
| abstract_inverted_index.comparison | 263 |
| abstract_inverted_index.conclusion | 317 |
| abstract_inverted_index.concordant | 300, 375 |
| abstract_inverted_index.considered | 172 |
| abstract_inverted_index.discordant | 392 |
| abstract_inverted_index.evaluation | 38 |
| abstract_inverted_index.identified | 427 |
| abstract_inverted_index.monitoring | 521 |
| abstract_inverted_index.percentage | 408 |
| abstract_inverted_index.persistent | 546 |
| abstract_inverted_index.smoldering | 11 |
| abstract_inverted_index.Background: | 0 |
| abstract_inverted_index.Birmingham, | 160 |
| abstract_inverted_index.GEM‐CESAR | 2, 99 |
| abstract_inverted_index.HLC+/NGF‐ | 403 |
| abstract_inverted_index.HLC‐/NGF+ | 398 |
| abstract_inverted_index.alternative | 34, 554 |
| abstract_inverted_index.anticipated | 570 |
| abstract_inverted_index.categorized | 333 |
| abstract_inverted_index.concordance | 527 |
| abstract_inverted_index.follow‐up | 449, 558 |
| abstract_inverted_index.guidelines. | 205 |
| abstract_inverted_index.heavy+light | 43 |
| abstract_inverted_index.high‐risk | 10 |
| abstract_inverted_index.maintenance | 128 |
| abstract_inverted_index.negativity. | 32 |
| abstract_inverted_index.potentially | 6 |
| abstract_inverted_index.procedures. | 142 |
| abstract_inverted_index.progressed. | 479 |
| abstract_inverted_index.progression | 572 |
| abstract_inverted_index.serological | 80 |
| abstract_inverted_index.suppression | 210, 425, 440 |
| abstract_inverted_index.carfilzomib, | 106 |
| abstract_inverted_index.discordances | 542 |
| abstract_inverted_index.lenalidomide | 107, 130 |
| abstract_inverted_index.maintenance, | 74 |
| abstract_inverted_index.progression. | 462 |
| abstract_inverted_index.HLC‐/NGF‐ | 387 |
| abstract_inverted_index.consolidation | 120 |
| abstract_inverted_index.dexamethasone | 109 |
| abstract_inverted_index.manufacturer. | 185 |
| abstract_inverted_index.respectively. | 344 |
| abstract_inverted_index.turbidimeter. | 166 |
| abstract_inverted_index.concentrations | 150, 168 |
| abstract_inverted_index.consolidation. | 445 |
| abstract_inverted_index.immunoglobulin | 234 |
| abstract_inverted_index.recommendations. | 194 |
| abstract_inverted_index.immunosuppression | 512 |
| abstract_inverted_index.Summary/Conclusion: | 519 |
| abstract_inverted_index.post‐consolidation | 271, 412, 467 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 35 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/2 |
| sustainable_development_goals[0].score | 0.5699999928474426 |
| sustainable_development_goals[0].display_name | Zero hunger |
| citation_normalized_percentile.value | 0.22658252 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |